Streetbeat News

Price Targets

DNTH

Dianthus Therapeutics (NASDAQ:DNTH) has been evaluated by 4 analysts over the past three months, with ratings ranging from bullish to bearish. The average 12-month price target has increased by 10.6% to $43.5. Analysts have maintained or adjusted their ratings and price targets, reflecting their views on the company's market position. Dianthus Therapeutics, a clinical-stage biotech company, has shown significant revenue growth but faces challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 12:00 pm

CROX

In the past three months, 7 analysts have rated Crocs (NASDAQ:CROX), with a majority being somewhat bullish. The average 12-month price target has increased by 3.77% to $161.71. Analysts have adjusted their ratings and price targets based on Crocs' financial performance, which includes a 3.65% revenue growth and a strong net margin of 20.59%. However, the company's debt-to-equity ratio is higher than the industry average.

Portfolio Pulse from Benzinga Insights

September 26, 2024 | 12:00 pm

ECL

Piper Sandler analyst Charles Neivert maintains an Overweight rating on Ecolab (NYSE:ECL) and raises the price target from $270 to $305.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:37 am

REG

Deutsche Bank has downgraded Regency Centers from Buy to Hold, while raising its price target from $70 to $75.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:33 am

LSPD

BMO Capital has maintained an 'Outperform' rating on Lightspeed Commerce and raised its price target from $18 to $20, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:24 am

META

Baird analyst Colin Sebastian maintains an Outperform rating on Meta Platforms and raises the price target from $530 to $605.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:21 am

MU

PRGS

ZETA

Three tech stocks, Micron Technology, Progress Software, and Zeta Global, are currently overbought according to RSI indicators. Despite recent gains, investors should be cautious as these stocks may be at risk of a pullback.

Portfolio Pulse from Avi Kapoor

September 26, 2024 | 11:21 am

ONON

Keybanc analyst Ashley Owens maintains an Overweight rating on On Holding (NYSE:ONON) and raises the price target from $47 to $60.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:18 am

CTAS

Baird analyst Andrew Wittmann maintains a Neutral rating on Cintas (NASDAQ:CTAS) and raises the price target from $194 to $209.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:18 am

MCD

Baird analyst David Tarantino has maintained an 'Outperform' rating on McDonald's and raised the price target from $280 to $320.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:15 am